Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability
DGX agentarXiv:2604.05478v2 Announce Type: replace-cross Abstract: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resi